Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff

被引:45
|
作者
Schmidt, Simone B. [1 ]
Grueter, Ludwig [2 ]
Boltzmann, Melanie [1 ]
Rollnik, Jens D. [1 ]
机构
[1] Hannover Med Sch, Associated Inst, Inst Neurorehabil Res, BDH Clin Hessisch Oldendorf, Hessisch Oldendorf, Germany
[2] Nordlab, Hameln, Germany
来源
PLOS ONE | 2020年 / 15卷 / 06期
关键词
D O I
10.1371/journal.pone.0235417
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The SARS-CoV-2 pandemic threatens health care providers and society. For planning of treatment capacities, it is of major importance to obtain reliable information on infection and fatality rates of the novel coronavirus. A German community study, the so-called Heinsberg study, found a 5-fold higher infection rate (and thus a remarkably lower fatality rate) than the officially reported cases suggest. We were interested to examine the SARS-CoV-2-IgG antibody status among clinic staff of a large neurological center in Northern Germany. Blood samples and questionnaires (demographic data, medical history) were collected pseudonymously. In total, 406 out of 525 (77.3%) of our employees participated in the study. The infection rate among the staff was as high as 2.7%. Including drop-outs (missing questionnaire but test result available), the infection rate was even higher (2.9%). Only 36% of the positively tested employees did suffer from flu-like symptoms in 2020. None of the nurses-having closest and longest contact to patients-were found to be positive. Despite the fact that the infection rate among clinic staff may not be directly compared to the situation in the surrounding county (due to different testing procedures), one might hypothesize that the infection rate could be more than 30-fold higher than the number of officially reported cases for the county of Hameln-Pyrmont. The high rate of IgG-positive, asymptomatic healthcare workers might help to overcome fears in daily work.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Highly active engineered IgG3 antibodies against SARS-CoV-2
    Kallolimath, Somanath
    Sun, Lin
    Palt, Roman
    Stiasny, Karin
    Mayrhofer, Patrick
    Gruber, Clemens
    Kogelmann, Benjamin
    Chen, Qiang
    Steinkellner, Herta
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (42)
  • [22] A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein
    Albecka, Anna
    Clift, Dean
    Vaysburd, Marina
    Rhinesmith, Tyler
    Caddy, Sarah L.
    Favara, David M.
    Baxendale, Helen E.
    James, Leo C.
    EMBO JOURNAL, 2021, 40 (17):
  • [23] The long-term dynamics of serum antibodies against SARS-CoV-2
    Sousa, Graziele Fonseca de
    Nogueira, Thuany da Silva
    Sales, Lana Soares de
    Maissner, Fernanda Ferreira
    de Oliveira, Odara Araujo
    Rangel, Hellade Lopes
    dos Santos, Daniele das Gracas
    Nunes-da-Fonseca, Rodrigo
    de Souza-Menezes, Jackson
    Nepomuceno-Silva, Jose Luciano
    Mury, Flavia Borges
    Gestinari, Raquel de Souza
    Tanuri, Amilcar
    Ferreira, Orlando da Costa, Jr.
    Monteiro-de-Barros, Cintia
    PEERJ, 2022, 10
  • [24] Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers
    Brant-Zawadzki, Michael
    Fridman, Deborah
    Robinson, Philip A.
    Zahn, Matthew
    Chau, Clayton
    German, Randy
    Breit, Marcus
    Burke, Elmira
    Bock, Jason R.
    Hara, Junko
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):
  • [25] Prevalence of SARS-CoV-2 Specific Antibodies in the Staff of a Children's Hospital, in Tehran, Iran
    Armin, Shahnaz
    Karbasian, Fereshteh
    Hoseinialfatemi, Seyedeh Mahsan
    Ghanaie, Roxana Mansour
    Tabatabaei, Sedigheh Rafiei
    Fahimzad, Seyed Alireza
    Rajabnejad, Maryam
    Khanbabaee, Ghamartaj
    Vaghefi, Soheila Sadat Vaghefi
    Imanzadeh, Farid
    Maham, Saeed
    Razmara, Raheleh
    Karimi, Abdollah
    Eshghi, Peyman
    Maghsudlu, Mahtab
    Arabkhazaeli, Ali
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (09) : 1 - 6
  • [26] The SARS-CoV-2 specific IgG antibodies biophotonic sensor
    Szczerska, Malgorzata
    Wityk, Pawel
    Listewnik, Paulina
    JOURNAL OF BIOPHOTONICS, 2023, 16 (01)
  • [27] Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
    Luo, Chunhua
    Liu, Min
    Li, Qianyuan
    Zheng, Xiaoling
    Ai, Wen
    Gong, Feng
    Fan, Jinhong
    Liu, Shaowei
    Wang, Xi
    Luo, Jun
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 : 57 - 62
  • [28] The endogenous factors affecting the detection of serum SARS-CoV-2 IgG/IgM antibodies by ELISA
    Liu, Weiping
    Long, Xia
    Wan, Kexing
    Yin, Minggang
    Yin, Yi
    Zhang, Bo
    Li, Lin
    Song, Yaohui
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1976 - 1982
  • [29] Detection of SARS-CoV-2 IgG antibodies in breast milk and serum of immunized lactating mothers
    Sadiq, Sidra
    Arslan, Faheem
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2022, 3 (01): : 30 - 33
  • [30] Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley
    Melotti, Roberto
    Scaggiante, Federica
    Falciani, Michela
    Weichenberger, Christian X.
    Foco, Luisa
    Lombardo, Stefano
    De Grandi, Alessandro
    von Laer, Dorothee
    Mahlknecht, Angelika
    Pramstaller, Peter P.
    Pagani, Elisabetta
    Meier, Horand
    Gaertner, Timon
    Troi, Christina
    Mascalzoni, Deborah
    Pattaro, Cristian
    Mian, Michael
    EPIDEMIOLOGY AND INFECTION, 2021, 149